EXSAMEK
DEAD

Serial Number

86278548

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 12, 2014

Add to watchlist:

No watchlists yet
View on USPTO

EXSAMEK Trademark

Serial Number: 86278548

EXSAMEK is a trademark filed by NOVARTIS AG on May 12, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 12, 2014

Registration Date

Not Registered

Published for Opposition

August 5, 2014

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 2, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 2, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 29, 2015 EXRA
SOU EXTENSION 2 GRANTED
Sep 28, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 25, 2015 AITU
SOU EXTENSION 2 FILED
Sep 17, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 17, 2015 EEXT
ASSIGNED TO EXAMINER
Jun 26, 2015 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2015 EXRA
SOU EXTENSION 1 GRANTED
Mar 18, 2015 EX1G
SOU EXTENSION 1 FILED
Mar 18, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 18, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2014 CNSA
ASSIGNED TO EXAMINER
Jun 27, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2014 NWOS
NEW APPLICATION ENTERED
May 15, 2014 NWAP